Search research articles
Contact Us
Filters
Showing results (41-50 of 109) with videos related to
Page
of 11
Sort By:
The Journal of Surgical Research
|
December 4, 2012
Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer
Changhua Zhang, Niranjan Awasthi, Margaret A Schwarz, et al.
The Journal of Surgical Research
|
June 15, 2007
Androgen receptor blockade in experimental combination therapy of pancreatic cancer
Srivani Konduri, Margaret A Schwarz, Danielle Cafasso, et al.
Journal of Cellular and Molecular Medicine
|
September 3, 2024
Telotristat ethyl, a tryptophan hydroxylase inhibitor, enhances antitumor efficacy of standard chemotherapy in preclinical cholangiocarcinoma models
Niranjan Awasthi, Lily Darman, Margaret A Schwarz, et al.
International Journal of Oncology
|
September 18, 2013
The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer
Chang-Ηua Zhang, Niranjan Awasthi, Margaret A Schwarz, et al.
Journal of Cellular Biochemistry
|
October 25, 2011
The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer
Niranjan Awasthi, Peter L Yen, Margaret A Schwarz, et al.
Cancer Letters
|
November 26, 2002
Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: implications for monotherapy and combination treatment
Roderich E Schwarz, Cecile A Donohue, David Sadava, et al.
The Journal of Surgical Research
|
December 19, 2023
Surgeon-Dependent Variability in Cost of Gastrointestinal Operations in a Single Cancer Center
Joy Sarkar, Richard P Roehner, Michael J Proulx, et al.
The American Journal of Case Reports
|
April 3, 2018
Managing the Unmanageable: A Two-Staged Palliative Resection to Control Life-Threatening Duodenal Bleeding Due to Recurrent Paraganglioma
Levi Y Smucker, Ashley N Hardy, Peter J O'Neil, et al.
Annals of Surgical Oncology
|
December 31, 2009
EMAP II-based antiangiogenic-antiendothelial in vivo combination therapy of pancreatic cancer
Roderich E Schwarz, Niranjan Awasthi, Srivani Konduri, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 19, 2013
Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II
Niranjan Awasthi, Changhua Zhang, Stefan Hinz, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 109) with videos related to
Sort By:
Page
of 11
The Journal of Surgical Research
|
December 4, 2012
Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer
Changhua Zhang, Niranjan Awasthi, Margaret A Schwarz, et al.
The Journal of Surgical Research
|
June 15, 2007
Androgen receptor blockade in experimental combination therapy of pancreatic cancer
Srivani Konduri, Margaret A Schwarz, Danielle Cafasso, et al.
Journal of Cellular and Molecular Medicine
|
September 3, 2024
Telotristat ethyl, a tryptophan hydroxylase inhibitor, enhances antitumor efficacy of standard chemotherapy in preclinical cholangiocarcinoma models
Niranjan Awasthi, Lily Darman, Margaret A Schwarz, et al.
International Journal of Oncology
|
September 18, 2013
The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer
Chang-Ηua Zhang, Niranjan Awasthi, Margaret A Schwarz, et al.
Journal of Cellular Biochemistry
|
October 25, 2011
The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer
Niranjan Awasthi, Peter L Yen, Margaret A Schwarz, et al.
Cancer Letters
|
November 26, 2002
Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: implications for monotherapy and combination treatment
Roderich E Schwarz, Cecile A Donohue, David Sadava, et al.
The Journal of Surgical Research
|
December 19, 2023
Surgeon-Dependent Variability in Cost of Gastrointestinal Operations in a Single Cancer Center
Joy Sarkar, Richard P Roehner, Michael J Proulx, et al.
The American Journal of Case Reports
|
April 3, 2018
Managing the Unmanageable: A Two-Staged Palliative Resection to Control Life-Threatening Duodenal Bleeding Due to Recurrent Paraganglioma
Levi Y Smucker, Ashley N Hardy, Peter J O'Neil, et al.
Annals of Surgical Oncology
|
December 31, 2009
EMAP II-based antiangiogenic-antiendothelial in vivo combination therapy of pancreatic cancer
Roderich E Schwarz, Niranjan Awasthi, Srivani Konduri, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 19, 2013
Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II
Niranjan Awasthi, Changhua Zhang, Stefan Hinz, et al.
Page
of 11